Worth Venture Partners, LLC - PROCESSA PHARMACEUTICALS INC ownership

PROCESSA PHARMACEUTICALS INC's ticker is PCSA and the CUSIP is 74275C205. A total of 19 filers reported holding PROCESSA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Worth Venture Partners, LLC ownership history of PROCESSA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$78,049
-51.2%
70,9540.0%0.05%
-53.1%
Q3 2022$160,000
-36.3%
70,9540.0%0.10%
-33.8%
Q2 2022$251,000
+17.3%
70,9540.0%0.15%
+49.5%
Q1 2022$214,000
-38.5%
70,9540.0%0.10%
-42.4%
Q4 2021$348,000
-55.4%
70,954
-22.0%
0.17%
-51.0%
Q3 2021$780,000
+4.7%
90,9680.0%0.35%
+26.7%
Q2 2021$745,000
-20.9%
90,9680.0%0.28%
-39.4%
Q1 2021$942,00090,9680.46%
Other shareholders
PROCESSA PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Coastal Bridge Advisors, LLC 52,500$13,1360.00%
Mirador Capital Partners LP 19,516$4,8830.00%
WELLS FARGO & COMPANY/MN 3,238$8100.00%
NORTHERN TRUST CORP 15,401$3,8530.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 152,670$38,9300.00%
STATE STREET CORP 42,786$10,9100.00%
MILLENNIUM MANAGEMENT LLC 25,930$6,6120.00%
BlackRock Inc. 293$730.00%
Citadel Advisors 166,224$42,3870.00%
View complete list of PROCESSA PHARMACEUTICALS INC shareholders